Valuation: Teva Pharmaceutical Industries Limited

Market Cap 43.66B 0 37.45B 34.97B 32.09B 60.34B 4,173B 61.33B 413B 162B 2,093B 164B 160B 6,921B P/E 2026 *
50.3x
P/E 2027 * 20.6x
Enterprise Value 55.54B 0 47.64B 44.49B 40.82B 76.76B 5,309B 78.02B 525B 206B 2,662B 209B 204B 8,803B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.02x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day-0.54%
1 week+1.83%
Current month+2.58%
1 month+15.64%
3 months+11.06%
6 months+3.91%
Current year+10.51%
1 week 10,650
Extreme 10650
11,240
1 month 9,396
Extreme 9396
11,240
Current year 8,860
Extreme 8860
11,350
1 year 5,990
Extreme 5990
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,310
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+1.83% - - 43.66B
+4.46%+4.92%+82.07%+134.31% 1,141B
+0.85%+4.81%+53.77%+58.51% 659B
+2.72%+6.92%+28.99%+77.15% 470B
+0.23%+1.71%+40.43%+44.91% 366B
+0.37%+3.20%+24.76%+41.89% 302B
+0.46%+3.47%+1.15%+13.49% 254B
+4.02%+6.29%+49.67%+68.96% 239B
-0.46%-0.07%-13.76%-52.74% 207B
+2.90%+8.63%+25.11%+94.52% 183B
Average +1.11%+4.10%+32.47%+53.44% 424.55B
Weighted average by Cap. +1.10%+4.31%+46.82%+74.19%

Financials

2026 *2027 *
Net sales 16.58B 0 14.22B 13.28B 12.19B 22.92B 1,585B 23.29B 157B 61.37B 795B 62.26B 60.91B 2,628B 17.3B 0 14.84B 13.86B 12.72B 23.91B 1,654B 24.31B 164B 64.04B 830B 64.97B 63.56B 2,743B
Net income 1.14B 0 978M 913M 838M 1.58B 109B 1.6B 10.78B 4.22B 54.67B 4.28B 4.19B 181B 2.34B 0 2B 1.87B 1.72B 3.23B 223B 3.28B 22.09B 8.65B 112B 8.77B 8.58B 370B
Net Debt 11.88B 0 10.19B 9.51B 8.73B 16.41B 1,135B 16.68B 112B 43.96B 569B 44.6B 43.63B 1,883B 8.61B 0 7.39B 6.9B 6.33B 11.9B 823B 12.1B 81.39B 31.87B 413B 32.33B 31.63B 1,365B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
20/08/26 ILA 11,150.00 -0.54% 33,120
19/08/26 ILA 11,210.00 +1.17% 937,718
18/08/26 ILA 11,080.00 +2.50% 750,535
17/08/26 ILA 10,810.00 +1.03% 620,299
14/08/26 ILA 10,700.00 -2.28% 587,382
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
37.47USD
Average target price
41.40USD
Spread / Average Target
+10.49%

Quarterly revenue - Rate of surprise